drugset
drugset / Trial / NCT04926246

A Study in Healthy Men to Find the Best Formulation of BI 685509 and to Test How it is Taken up in the Body

NCT04926246 ↗

Phase 1 Completed 39 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The main objective of this trial is to select a formulation and to optimize the identified formulation of BI 685509, if needed.

Timeline

Start
2021-07-01
Primary completion
2022-02-07
Completion
2022-02-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Reference Product X Unknown — Oral
Subject Reference Product Y Unknown — Oral
Subject Reference Product Z Unknown — Oral
Subject Test Product M Unknown — Oral
Subject Test Product N Unknown — Oral
Subject Test Product O Unknown — Oral
Subject Test Product P Unknown — Oral
Subject Test Product Q Unknown — Oral
Subject Test Product S Unknown — Oral
Subject Test Product U Unknown — Oral

Indications

No indication recorded.